Lubner David Charles insider trades
Lubner David Charles has filed 33 Form 4s with the SEC that we hold, for ACLX (Director), Dyne Therapeutics, Inc. (DYN) (Director), PNT (Director) and CRGX (Director), among 8 companies in all. Across all of them we count 2 purchases worth $1.0M and 1 sale worth $450.0K reported on Form 4. In the last 12 months: 1 purchase ($1,000.0K) and 1 sale ($450.0K). The largest single trade was a purchase of 55,555 shares of Braveheart Bio, Inc. worth $1,000.0K, dated 2026-08-07. The first filing on our record is dated 2021-07-08 and the latest 2026-08-07.
ACLX
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-01-20 | S, sale reported on Form 4 | 6,000 | $450.0K | 2026-01-20 |
Dyne Therapeutics, Inc. (DYN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
PNT
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-11-23 | P, purchase reported on Form 4 | 3,600 | $24.7K | 2022-11-28 |
CRGX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Vor Biopharma Inc. (VOR)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Disc Medicine, Inc. (GMTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Crescent Biopharma, INC. (CBIO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Braveheart Bio, Inc. (BRVE)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-08-07 | P, purchase reported on Form 4 | 55,555 | $1,000.0K | 2026-08-07 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1572000) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms